168 related articles for article (PubMed ID: 36714021)
21. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
Li F; Guo P; Dong K; Guo P; Wang H; Lv X
J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
[No Abstract] [Full Text] [Related]
22. Langerhans cell histiocytosis in Chinese adults: absence of BRAF mutations and increased FOXP3(+) regulatory T cells.
Tong C; Jia X; Jia Y; He Y
Int J Clin Exp Pathol; 2014; 7(6):3166-73. PubMed ID: 25031736
[TBL] [Abstract][Full Text] [Related]
23. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis.
Senechal B; Elain G; Jeziorski E; Grondin V; Patey-Mariaud de Serre N; Jaubert F; Beldjord K; Lellouch A; Glorion C; Zerah M; Mary P; Barkaoui M; Emile JF; Boccon-Gibod L; Josset P; Debré M; Fischer A; Donadieu J; Geissmann F
PLoS Med; 2007 Aug; 4(8):e253. PubMed ID: 17696642
[TBL] [Abstract][Full Text] [Related]
24. Differentially Infiltrated Identification of Novel Diagnostic Biomarkers Associated with Immune Infiltration in Nasopharyngeal Carcinoma.
Gao P; Lu W; Hu S; Zhao K
Dis Markers; 2022; 2022():3934704. PubMed ID: 36438903
[TBL] [Abstract][Full Text] [Related]
25. Does CD1a Expression Influence T Cell Function in Patients With Langerhans Cell Histiocytosis?
Mitchell J; Kannourakis G
Front Immunol; 2021; 12():773598. PubMed ID: 34956202
[TBL] [Abstract][Full Text] [Related]
26. Co-existence of Langerhans cell histiocytosis and reticulohistiocytosis with initial presentation of skull lesions: A case report.
Shen WC; Chang Liao NF; Lin TY; Wu PY
J Cutan Pathol; 2019 Jan; 46(1):62-66. PubMed ID: 30251332
[TBL] [Abstract][Full Text] [Related]
27. Circulating cell-free BRAF
Héritier S; Hélias-Rodzewicz Z; Lapillonne H; Terrones N; Garrigou S; Normand C; Barkaoui MA; Miron J; Plat G; Aladjidi N; Pagnier A; Deville A; Gillibert-Yvert M; Moshous D; Lefèvre-Utile A; Lutun A; Paillard C; Thomas C; Jeziorski E; Nizard P; Taly V; Emile JF; Donadieu J
Br J Haematol; 2017 Aug; 178(3):457-467. PubMed ID: 28444728
[TBL] [Abstract][Full Text] [Related]
28. Gene network in pulmonary tuberculosis based on bioinformatic analysis.
Li L; Lv J; He Y; Wang Z
BMC Infect Dis; 2020 Aug; 20(1):612. PubMed ID: 32811479
[TBL] [Abstract][Full Text] [Related]
29. Concurrent langerhans cell histiocytosis and B-lineage lymphoid proliferation in the bone marrow.
Kim M; Kang HJ; Shin HY; Ahn HS; Lee DS
Korean J Lab Med; 2009 Oct; 29(5):402-5. PubMed ID: 19893348
[TBL] [Abstract][Full Text] [Related]
30. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms].
Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R
Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680
[TBL] [Abstract][Full Text] [Related]
31. Detection of clonal lymphoid receptor gene rearrangements in langerhans cell histiocytosis.
Chen W; Wang J; Wang E; Lu Y; Lau SK; Weiss LM; Huang Q
Am J Surg Pathol; 2010 Jul; 34(7):1049-57. PubMed ID: 20551822
[TBL] [Abstract][Full Text] [Related]
32. Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci.
Egeler RM; Katewa S; Leenen PJ; Beverley P; Collin M; Ginhoux F; Arceci RJ; Rollins BJ;
Pediatr Blood Cancer; 2016 Oct; 63(10):1704-12. PubMed ID: 27314817
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis.
Murakami I; Matsushita M; Iwasaki T; Kuwamoto S; Kato M; Nagata K; Horie Y; Hayashi K; Imamura T; Morimoto A; Imashuku S; Gogusev J; Jaubert F; Takata K; Oka T; Yoshino T
Cell Commun Signal; 2015 Feb; 13():13. PubMed ID: 25889448
[TBL] [Abstract][Full Text] [Related]
34. Clinical Analysis of 122 Cases of Langerhans Cell Histiocytosis.
Wang T; Su B; Han D; Tong A; Li J; Liu Y; Jin H; Fang K
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Apr; 39(2):206-210. PubMed ID: 28483018
[TBL] [Abstract][Full Text] [Related]
35. Oral manifestations of Langerhans cell histiocytosis with unusual histomorphologic features.
AbdullGaffar B; Awadhi F
Ann Diagn Pathol; 2020 Aug; 47():151536. PubMed ID: 32454442
[TBL] [Abstract][Full Text] [Related]
36. Pathogenesis of Langerhans cell histiocytosis.
Badalian-Very G; Vergilio JA; Fleming M; Rollins BJ
Annu Rev Pathol; 2013 Jan; 8():1-20. PubMed ID: 22906202
[TBL] [Abstract][Full Text] [Related]
37. Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.
Tan W; Liu M; Wang L; Guo Y; Wei C; Zhang S; Luo C; Liu N
BMC Cancer; 2021 Feb; 21(1):126. PubMed ID: 33549054
[TBL] [Abstract][Full Text] [Related]
38. [Pathophysiology and treatment of adult Langerhans cell histiocytosis].
Tojo A; Kobayashi M
Rinsho Ketsueki; 2020; 61(9):1028-1034. PubMed ID: 33162496
[TBL] [Abstract][Full Text] [Related]
39. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.
Egeler RM; Favara BE; van Meurs M; Laman JD; Claassen E
Blood; 1999 Dec; 94(12):4195-201. PubMed ID: 10590064
[TBL] [Abstract][Full Text] [Related]
40. Identification of key genes in the tumor microenvironment of lung adenocarcinoma.
Long W; Li Q; Zhang J; Xie H
Med Oncol; 2021 Jun; 38(7):83. PubMed ID: 34117948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]